The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Morepen Laboratories's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Morepen Laboratories's Dividend Payout Ratio or its related term are showing as below:
NSE:MOREPENLAB'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.15 Med: 0.15 Max: 0.15
Current: 0.15
During the past 13 years, the highest Dividend Payout Ratio of Morepen Laboratories was 0.15. The lowest was 0.15. And the median was 0.15.
NSE:MOREPENLAB's Dividend Payout Ratio is ranked better than 82.88% of 444
companies
in the Drug Manufacturers industry
Industry Median: 0.375
vs NSE:MOREPENLAB: 0.15
During the past 13 years, the highest Trailing Annual Dividend Yield of Morepen Laboratories was 0.59%. The lowest was 0.38%. And the median was 0.48%.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Morepen Laboratories (NSE:MOREPENLAB) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Morepen Laboratories Dividend Payout Ratio Related Terms
Morepen Laboratories Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Morepen Laboratories's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:MOREPENLAB vs ZTS: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Morepen Laboratories's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Morepen Laboratories Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Morepen Laboratories's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Morepen Laboratories's Dividend Payout Ratio falls into.
Morepen Laboratories Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Morepen Laboratories's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Morepen Laboratories (NSE:MOREPENLAB) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Morepen Laboratories and its competitors. Over the past decade, Morepen Laboratories' Dividend Payout Ratio has ranged from 0.15 to 0.15. According to the industry distribution chart, Morepen Laboratories ranks #76 out of 444 companies in the Drug Manufacturers industry, placing it in the top 17.1%.
Is Morepen Laboratories' Dividend Payout Ratio too high?
Morepen Laboratories' current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.15 to a high of 0.15. Based on the distribution chart, Morepen Laboratories ranks #76 out of 444 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Morepen Laboratories has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Morepen Laboratories' Dividend Payout Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Morepen Laboratories ranks #76 out of 444 companies for Dividend Payout Ratio. This places Morepen Laboratories in the top 17% of its industry — outperforming the majority of peers. The industry median Dividend Payout Ratio is 0.38. Historically, Morepen Laboratories' own Dividend Payout Ratio has ranged from 0.15 to 0.15 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 444 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Morepen Laboratories and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Morepen Laboratories's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Morepen Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Morepen Laboratories (NSE:MOREPENLAB) is currently considered Fairly Valued. The stock's GF Value™ is ₹49.82, compared to a current price of ₹53.16 — trading 6.7% above its estimated fair value. The current Dividend Payout Ratio is 0.00. Morepen Laboratories' overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Morepen Laboratories (NSE:MOREPENLAB), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Morepen Laboratories (NSE:MOREPENLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Morepen Laboratories stock appears to be overvalued.
The current stock price of ₹53.16 is trading 6.7% above its estimated GF Value™ of ₹49.82.
GuruFocus considers Morepen Laboratories to be Fairly Valued.
Key valuation signals for NSE:MOREPENLAB:
Dividend Payout Ratio: 0.00
GF Value™: ₹49.82 vs. price of ₹53.16 (6.7% above fair value)
No single metric tells the full story. See the NSE:MOREPENLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Morepen Laboratories Ltd is in the business of manufacturing, producing, developing, and marketing various Active Pharmaceutical Ingredients (APIs), branded and generic formulations, and also Home Health products. Some of the products offered by the company include various drug formulations, APIs, digital thermometers, heat belts, pulse oximeters, nutritional tablets, pain sprays, and others. The company operates in a single segment namely, Pharmaceuticals. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and the Rest of the world.
74GF Score
Get the complete analysis for NSE:MOREPENLAB
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MOREPENLAB has been successfully added to your 
